Evidence Grows of the Effectiveness of Rapid-Acting Brain Stimulation to Treat Bipolar Depression
New research is providing additional evidence of the effectiveness and safety of SAINT, a rapid-acting non-invasive brain stimulation therapy, to treat people suffering from bipolar depression.
SAINT iTBS Protocol Shows Promise for Bipolar I Depression
Miles for Migraine San Diego
SAINT protocol rapidly reduced depressive symptoms in bipolar I disorder, achieving 60% remission within a month post-treatment without adverse cognitive or manic effects.
Innovative Leaders: Modern Luxury Spotlight (MD. Mohamed Ahmed)
This work leads to the hypothesis that finding a way to maintain proper polyphosphate levels in the brain could possibly slow the progress of neurodegenerative disease. But proving that will still take large investments of time and money, and there will likely be new mysteries to be solved along the way.
DOI: 10.1371/journal.pbio.3002650
Targeted neurostimulation shows promise in reducing PTSD symptoms in veterans
Miles for Migraine hosted its 6th annual 2-mile Walk, 5K Run and Relax San Diego Event hosted on November 2nd at Liberty Station Park. This event was a fundraiser for Migraine & Headache Awareness, Treatment & Research. Kaizen Brain Center connected with local migraine & headache community, and sponsored events in the festival area.
Kaizen Brain Center’s SAINT TMS Ribbon-Cutting Ceremony
Dr. Mohammed Ahmed, MD, was featured in the Innovative Leaders section of the Modern Luxury Spotlight for his contributions to brain and mental health at Kaizen Brain Center.
Traumatic Brain Injury (TBI) and Dementia Progression
A recent study by MD. Shan H. Siddiqi identified a brain circuit linked to PTSD in veterans and showed that reducing connectivity via transcranial magnetic stimulation correlated with PTSD symptom improvement. Article’s DOI: https://doi.org/10.1038/s41593-024-01772-7
8th International Conference on Neurology and Brain Disorders (CPD Accredited)
Kaizen Brain Center Hosted a Ribbon-Cutting Ceremony Commemorating the Availability of the FDA-Approved SAINT® Neuromodulation System for Treatment-Resistant Major Depression in the Greater San Diego Area.
Magnus Medical Announces Commercial Launch of Groundbreaking SAINT Neuromodulation System
Ahmed, Mohammed & Besser, Lilah & Galasko, Douglas & Salmon, David & Kukull, Walter. (2016). TRAUMATIC BRAIN INJURY (TBI) AND DEMENTIA PROGRESSION. Alzheimer’s & Dementia. 12.
Magnus Medical Announces Commercial Launch of Groundbreaking SAINT Neuromodulation System
Neurology Congress 2023 scheduled on November 08-09, 2023, Dubai, UAE
November is a month dedicated to increased awareness of Alzheimer’s disease. So, what can we do as individuals? Lifestyle choices can help reduce the risks.